Collaborative Genomic Studies of Tourette Disorder
Project Description:
The Collaborative Genomic Studies of Tourette Disorder is a clinical trial led by Barbara Coffey. The study aims to identify genetic factors that contribute to Tourette's disorder and related disorders, such as Chronic Tics disorders. The study is currently open for enrollment
Core Function(s):
Training Trainees, Performing Research or Evaluation, Continuing Education/Community Training, Other Direct/Model Services, Demonstration Services
Area of Emphasis
Health-Related Activities
Target Audience:
Students/Trainees (long or intermediate trainees), Professionals and Para-Professionals, Adults with Disabilities, Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Racial or Ethnic Minorities, Disadvantaged Circumstances, Limited English, Geographic Areas, Empowerment Zone, Renewal Community, Reservation, Rural/Remote, Urban, Territory
Primary Target Audience Geographic Descriptor:
International
COVID-19 Related Data:
N/A